Brain swelling was a common side-effect in up to a third of patients in the donanemab trial. For most, this resolved without causing symptoms. However, two volunteers, and possibly a third, died as a result of dangerous swelling in the brain.
2 Likes
Nice. Good to hear they are making progress in this area. 50% of my grandparents had alzheimers near the end of their lives. Definitely something to avoid if possible.
1 Like
I don’t know how I feel about this.
Brain swelling is a serious and potentially deadly side effect and it might be more common than they thought
1 Like
This topic was automatically closed 14 days after the last reply. New replies are no longer allowed.